| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 150.23B | 147.19B | 143.98B | 147.67B | 138.60B | 104.92B |
| Gross Profit | 21.47B | 20.92B | 18.01B | 21.11B | 19.30B | 15.36B |
| EBITDA | 20.48B | 19.83B | 16.66B | 18.19B | 16.10B | 12.34B |
| Net Income | 3.76B | 3.62B | 590.00M | 5.07B | 5.10B | 2.63B |
Balance Sheet | ||||||
| Total Assets | 164.91B | 163.66B | 147.77B | 142.79B | 134.85B | 117.72B |
| Cash, Cash Equivalents and Short-Term Investments | 6.53B | 6.13B | 4.29B | 3.11B | 2.94B | 4.24B |
| Total Debt | 67.55B | 64.02B | 57.98B | 57.20B | 58.55B | 54.76B |
| Total Liabilities | 100.94B | 98.30B | 86.85B | 85.47B | 85.97B | 77.62B |
| Stockholders Equity | 62.76B | 62.01B | 58.65B | 55.06B | 46.83B | 38.34B |
Cash Flow | ||||||
| Free Cash Flow | 10.29B | 10.22B | 7.07B | 8.54B | 2.36B | -5.21B |
| Operating Cash Flow | 16.86B | 16.46B | 14.93B | 18.34B | 10.57B | 600.00M |
| Investing Cash Flow | -13.24B | -12.89B | -8.83B | -10.70B | -8.17B | -6.71B |
| Financing Cash Flow | -3.70B | -1.96B | -5.27B | -7.78B | -4.13B | 4.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥5.27T | 19.07 | ― | 1.41% | 13.61% | 17.01% | |
73 Outperform | ¥9.48T | 26.69 | 8.95% | 1.88% | 5.02% | 2.02% | |
67 Neutral | ¥40.73B | 12.31 | ― | 4.53% | 5.02% | 354.47% | |
67 Neutral | ¥158.27B | 11.45 | ― | 2.18% | -4.77% | -62.32% | |
65 Neutral | ¥771.48B | 15.62 | ― | 2.57% | 5.15% | -47.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | ¥65.38B | 9.09 | 2.26% | ― | 5.14% | 32.69% |